⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BDRX News
Biodexa Pharmaceuticals plc American Depositary Shs
Tanner Pharma Group e Biodexa lanciano il programma globale di accesso anticipato per i pazienti affetti da FAP
businesswire.com
BDRX
Tanner Pharma Group en Biodexa lanceren wereldwijd programma voor vroegtijdige toegang voor FAP-patiënten
businesswire.com
BDRX
Tanner Pharma Group et Biodexa lancent un programme mondial d’accès anticipé destiné aux patients atteints de polypose adénomateuse familiale
businesswire.com
BDRX
Tanner Pharma Group und Biodexa starten globales Early-Access-Programm für FAP-Patienten
businesswire.com
BDRX
Preliminary Results for the Year Ended 31 December 2025
globenewswire.com
BDRX
PFE
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
globenewswire.com
BDRX
ADR Ratio Change
globenewswire.com
BDRX
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
globenewswire.com
BDRX
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
accessnewswire.com
BDRX
GSK
PFE
NVS
COGT
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
globenewswire.com
BDRX